NCT00121771View on ClinicalTrials.gov

Malaria Candidate Vaccines FP9 Circumsporozoite (CS) and MVA CS in Adult Gambian Men

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

July 31, 2004

Conditions

Malaria

Interventions

BIOLOGICAL

FP9 CS

BIOLOGICAL

MVA CS

Trial Locations (1)

P.O.Box 273, Banjul

Medical Research Council Laboratories, Banjul

Sponsors

Collaborators (1)

Medical Research Council

All Listed Sponsors

collaborator

Medical Research Council

OTHER_GOV

collaborator

University of Oxford

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER